PRECISION MEDICINE

Market Trends: Lab-Retail Collaboration Remains Strong Despite Theranos Debacle

The Theranos debacle hasn't dissuaded retailers from partnering with labs. LabCorp & Walgreens Walgreens, Theranos's ex-retail partner, has moved on and entered into an agreement with another … [Read more...]

MARKETING

Genetic Testing: 23andMe Gets FDA Clearance for Direct-to-Consumer Marketing of Personal Genome Service

The FDA is allowing direct-to-consumer marketing, with special controls, of the 23andMe Personal Genome Service Pharmacogenetic Reports test for genetic variants to detect 33 variants for multiple … [Read more...]

DISTRIBUTION AGREEMENTS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

As the year winds down, diagnostic deals aren't as plentiful. Nevertheless, there have been some significant transactions. Here's a recap of the key activity from mid-October through the third week of … [Read more...]

MARKETING

Industry Trends: Continued Momentum for Lab-Retail Collaboration

The Theranos debacle hasn't dissuaded retailers from partnering with labs. Here's a rundown of some recent deals. LabCorp & Walgreens In fact, Walgreens, Theranos's ex-retail partner, has moved … [Read more...]

MARKETING

Dealing with Consumers: Using Patient Online Reviews to Boost Your Lab Business

Patients are making increasing use of physician rating and review sites to comment on their medical experiences the way diners do with restaurants. And as with restaurants, this can be a tremendous … [Read more...]

INNOVATION

LDTs: FDA Approves First NGS Residual Cancer Detection Test

The FDA broke new ground by allowing marketing of Adaptive Biotechnologies' ClonoSEQ assay, a next generation sequencing (NGS)-based test for minimal residual disease (MRD) in patients with acute … [Read more...]

PARTNERSHIPS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

The swirl of autumn leaves has brought a swirl of diagnostic deals. Here's a recap of the key activity from mid-September through the third week of October. M&A and Asset Sales Quest Diagnostics … [Read more...]

CUSTOMER SERVICE

Lab Leaders Have New Opportunities in the Age of Consumerism

The G2 Power Panel provided attendees at the 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) an opportunity to learn how some of the nation's leading laboratories are navigating the current … [Read more...]

OUTREACH ASSETS

Attendees Given Insider’s Look at a Hospital Laboratory Joint Venture

Hospital systems are increasingly exploring joint ventures as a means to monetize some of the hospital outreach laboratory's assets without exiting the business. Attendees at G2's 36th annual … [Read more...]

ACQUISITIONS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Amid back to school season, companies were back to making diagnostic deals. Here's a recap of the key activity from mid-August through the third week of September.  M&A and Asset Sales This … [Read more...]


(-00000g2)